Mehta Analysis: How Relevant Is Traditional Pharma In Sustainable Healthcare?
Executive Summary
What will the healthcare industry look like over the next generation – and what role should biopharma industry managers imagine for their sustainable success? Viren Mehta, founding partner of Mehta Partners, LLC, explores the challenges for pharma companies.
You may also be interested in...
Novartis CEO-Designate Set To Bring More Automation To Drug Discovery
Vasant Narasimhan, who is replacing Joseph Jimenez as Novartis' CEO next year, is an advocate of automation and artificial intelligence in future drug discovery.
Mehta Analysis: Shaming Biopharma Managers
Shame has historically been used as an effective tool in bringing about a change in pricing policy within an industry. But could it be wielded against the pharma industry today? Viren Mehta, founding partner of Mehta Partners, LLC, considers.
Mehta Analysis: The Promise Of 2021
Next year promises a wide range of opportunities for biopharma, triggered by an all-in commitment by every company with something to combat – COVID-19. Viren Mehta of Mehta Partners LLC discusses.